[go: up one dir, main page]

NO20043735L - Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene - Google Patents

Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene

Info

Publication number
NO20043735L
NO20043735L NO20043735A NO20043735A NO20043735L NO 20043735 L NO20043735 L NO 20043735L NO 20043735 A NO20043735 A NO 20043735A NO 20043735 A NO20043735 A NO 20043735A NO 20043735 L NO20043735 L NO 20043735L
Authority
NO
Norway
Prior art keywords
acylaminoalkenylenamide
intestines
derivatives
motility disorders
functional motility
Prior art date
Application number
NO20043735A
Other languages
English (en)
Norwegian (no)
Inventor
John R Fozard
Hans-Juergen Pfannkuche
Weber Eckhard
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20043735L publication Critical patent/NO20043735L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
NO20043735A 2002-02-08 2004-09-07 Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene NO20043735L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0203061.7A GB0203061D0 (en) 2002-02-08 2002-02-08 Organic compounds
PCT/EP2003/001227 WO2003066062A1 (fr) 2002-02-08 2003-02-07 Utilisation de derives d'acylaminoalcenylene-amide dans le traitement de troubles de la motilite fonctionnelle viscerale

Publications (1)

Publication Number Publication Date
NO20043735L true NO20043735L (no) 2004-09-07

Family

ID=9930743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043735A NO20043735L (no) 2002-02-08 2004-09-07 Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene

Country Status (18)

Country Link
US (2) US20050203164A1 (fr)
EP (2) EP2216025A3 (fr)
JP (2) JP2005516994A (fr)
KR (2) KR20040081492A (fr)
CN (1) CN1301714C (fr)
AU (1) AU2003244446B2 (fr)
BR (1) BR0307479A (fr)
CA (1) CA2471964A1 (fr)
GB (1) GB0203061D0 (fr)
IL (2) IL162816A0 (fr)
MX (1) MXPA04007640A (fr)
NO (1) NO20043735L (fr)
NZ (1) NZ534231A (fr)
PL (1) PL370255A1 (fr)
RU (1) RU2353356C2 (fr)
TW (1) TWI330177B (fr)
WO (1) WO2003066062A1 (fr)
ZA (1) ZA200404960B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
MXPA06004688A (es) * 2003-10-27 2006-07-05 Novartis Ag Uso de antagonistas de neuroquinina en el tratamiento de incontinencia urinaria.
JP2010502736A (ja) 2006-09-08 2010-01-28 オレ・ファーマシューティカルズ・インコーポレーテッド 消化管の炎症を低減または軽減するための方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
EA002348B1 (ru) * 1995-02-22 2002-04-25 Новартис Аг Соединения 1-арил-2-ациламиноэтана и их применение в качестве антагонистов нейрокинина, в частности нейрокинина 1
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
DE69838421D1 (en) * 1997-07-02 2007-10-25 Merck & Co Inc Polymorphe form des tachykininrezeptorantagonisten 2-(r)-(1-(r)-(3,5-bis(trifluormethyl)phenyl)ethoxy)-3-(s)-(4-fluor)phenyl-4-(3-5-oxo-1h,4h-1,2,4-triazolo)methylmorpholin
TW520370B (en) * 1998-11-20 2003-02-11 Meiji Seika Kaisha Benzooxazole derivatives and a pharmaceutical composition containing the derivatives as an active ingredient
RU2161894C1 (ru) * 1999-08-10 2001-01-20 НИФ "Ультрасан" Лечебно-профилактическая композиция
GB0010958D0 (en) 2000-05-05 2000-06-28 Novartis Ag Organic compounds
WO2002051440A1 (fr) * 2000-12-22 2002-07-04 Takeda Chemical Industries, Ltd. Medicaments de combinaison
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
NZ534231A (en) 2007-02-23
JP2010241835A (ja) 2010-10-28
TWI330177B (en) 2010-09-11
CA2471964A1 (fr) 2003-08-14
TW200302818A (en) 2003-08-16
PL370255A1 (en) 2005-05-16
CN1301714C (zh) 2007-02-28
AU2003244446B2 (en) 2006-08-10
US20050203164A1 (en) 2005-09-15
HK1077749A1 (en) 2006-02-24
RU2353356C2 (ru) 2009-04-27
US20070293473A1 (en) 2007-12-20
CN1627947A (zh) 2005-06-15
RU2004127132A (ru) 2005-06-10
EP2216025A3 (fr) 2010-11-10
IL162816A (en) 2010-11-30
EP2216025A2 (fr) 2010-08-11
IL162816A0 (en) 2005-11-20
BR0307479A (pt) 2004-12-07
JP2005516994A (ja) 2005-06-09
ZA200404960B (en) 2006-05-31
GB0203061D0 (en) 2002-03-27
WO2003066062A1 (fr) 2003-08-14
AU2003244446A1 (en) 2003-09-02
MXPA04007640A (es) 2004-11-10
KR20040081492A (ko) 2004-09-21
EP1476167A1 (fr) 2004-11-17
KR20100100994A (ko) 2010-09-15

Similar Documents

Publication Publication Date Title
DE60328671D1 (de) Neue aminobenzamidderivate
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
ATE411996T1 (de) Kondensierte azolpyrimidinderivate
ATE352550T1 (de) Chinazolinderivate
ATE420066T1 (de) Amidoacetonitrilderivate
NO20043696L (no) Gamma-sekretaseinhibitorer
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
ATE395345T1 (de) Imidazol-4-yl-ethynyl-pyridin-derivate
IS8352A (is) Ný rópínírólsamsetning
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
BRPI0312048A2 (pt) conjunto para redução de dobras
ATE354365T1 (de) N-thiazol-2-yl-benzamid-derivate
DK1706373T3 (da) Amidoacetonitrilderivater
DE60326190D1 (de) des Körpers
DE60321998D1 (de) Optometrisches Instrument
IS8045A (is) Púrín-6-ón-afleiður
DE50306277D1 (de) 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
NO20043735L (no) Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene
PL1786759T3 (pl) Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
DE10394115D2 (de) Schabewärmetauscher
DE10394144D2 (de) Duschvorrichtung
HUP0203929D0 (en) New use of substituted alkyl-piridazinone derivatives
FR2858206B1 (fr) Extensiometre de la peau
DOP2003000677A (es) Derivados benzofurado y benzotiofeno utiles en el tratamiento de desordenes hiper-proliferativos
UA7131S (uk) Рушникова сушарка

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application